RNA, U6 small nuclear 632, pseudogene (RNU6-632P)

RNA, U6 small nuclear 632, pseudogene (RNU6-632P) is classified as a **pseudogene** for U6 small nuclear RNA (snRNA), a highly conserved non-coding RNA component involved in the catalytic core of the spliceosome—the molecular machinery responsible for the removal of introns from pre-mRNA in eukaryotic cells[1][3][5]. While U6 snRNA is critical for splicing and cell viability, the RNU6-632P locus represents a non-functional, typically non-expressed genomic sequence derived from ancestral U6 snRNA genes[5][6]. Pseudogenes like RNU6-632P are not translated into functional products, lack direct biological activity, and are not considered therapeutic targets or disease-associated genes[6]. Their biological effect, if any, is not established and current evidence does not attribute any meaningful function, disease association, or interaction with drugs to these loci. **Note:** There is no evidence that RNU6-632P encodes a receptor, enzyme, or other targetable protein or RNA. This entry is a **pseudogene**, not a canonical therapeutic target, and should not be considered a receptor or similar pharmacological target[6]. **Key points supporting assessment:** - U6 snRNA is functionally essential, but RNU6-632P is specifically annotated as a pseudogene, not involved in active splicing or gene regulation[1][5][6]. - Pseudogenes may arise by duplication or retrotransposition, often containing sequence features reminiscent of the parent gene but generally lacking promoter activity or functional transcription[5]. - No biological function, drug interaction, or disease association is established for individual U6 snRNA pseudogenes in the human genome[6]. - The existence of “many copies” (including numerous pseudogenes) is characteristic of the U6 gene family, but only the active, canonical U6 snRNA genes are functional[1][5].

Other names

RNU6-632PRNA, U6 small nuclear 632, pseudogene